Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.
Sponsor: Columbia University
Summary
This is a single center brain Positron Emission Tomography (PET) study of 18F-MK-6240. Eligible participants are persons from Northern Manhattan who self-identify as Hispanic, non-Hispanic Black, or Non-Hispanic White, who are 55 to 69 years of age, of both sexes, without dementia, who have already agreed to undergo, of have undergone, brain amyloid PET and magnetic resonance imaging (MRI). Those eligible will have one brain PET scan with 18F-MK-6240, repeated after 18 months to 30 months. Vital signs will be checked prior to injection of 18F-MK-6240 and again at the completion of the PET scan. The primary objective is to relate diabetes status and glycemia to in-vivo brain tau accumulation, across and within ethnic and racial groups.
Official title: Tau Positron Emission Tomography (PET) Imaging in the Northern Manhattan Study of Metabolism and Mind (NOMEM) With 18F-MK6240.
Key Details
Gender
All
Age Range
55 Years - 69 Years
Study Type
INTERVENTIONAL
Enrollment
600
Start Date
2018-07-24
Completion Date
2026-06
Last Updated
2025-05-06
Healthy Volunteers
Yes
Conditions
Interventions
18F-MK6240 injection
Intravenous injection of 18F-MK-6240, up to 5 mCi (185 MBq), total of one injection per PET scan (2 injections in total with an interval of 18 to 30 months)
Locations (1)
Columbia University Irving Medical Center
New York, New York, United States